Skip to main content
. 2023 Jun 7;12(4):1079–1093. doi: 10.1007/s40122-023-00530-0

Table 2.

Study and patient characteristics

Study Country Design Therapy in experimental group Therapy in control group Simple size Method Dosage Pain assessment tools Inclusion population
Trial Control
Mahboub Pouraghaei et al. [19] Iran RCT Ketamine Morphine 95 89

Ketamine: intranasal

Morphine: intravenous

Ketamine: 1 mg/kg

Morphine: 0.1 mg/kg

NRS The patients over age 18 years with a history of nephrolithiasis and complaints of flank pain similar to their previous pain and patients with acute flank pain suggesting renal colic were included in the study
Arash Forouzan et al. [20] Iran RCT Ketamine Morphine 68 68

Ketamine: intravenous

Morphine: intravenous

Ketamine: 0.3 mg/kg

Morphine: 0.1 mg/kg

VAS The nausea, vomiting, urinary stimulation, tenderness in the costovertebral region, visual analog scale (VAS) > 5 in patients with renal colic due to stones (confirmed by imaging), age of 18–65 years, and informed consent to enter the study
Mohammad Reza Farnia et al. [21] Iran RCT Ketamine Morphine 20 20

Ketamine: intranasal

Morphine: intravenous

Ketamine: 1 mg/kg

Morphine: 0.1 mg/kg

VAS Eligible patients were older than 15 years' old who presented to the ED because of renal colic pain and they did not need any surgical intervention for their urolithiasis. The diagnosis was confirmed by ultrasound evidence of renal stone and hematuria in urine analysis
Javad Mozafari et al. [22] Iran RCT Ketamine Fentanyl 65 65

Ketamine: intranasal

Fentanyl: intravenous

Ketamine: 1 mg/kg

Fentanyl: 1 μg/kg

VAS The eligible candidates included all 15 to 65-year-old patients with typical kidney stone symptoms presenting to the hospital
Maryam Ziaei et al. [23] Iran RCT Ketamine Morphine 100 100

Ketamine: intranasal

Morphine: intravenous

Ketamine: 1.5 mg/kg

Morphine: 0.1 mg/kg

VAS Inclusion criteria include patients with known history of renal stone, acute renal pain with score ≥ four based on visual analogue scale (VAS) and with age between 20 and 50 years and with no other underlying diseases

RCT randomized controlled trials; NRS numerical rating scale; VAS visual analogue scale